Standard BioTools Inc.
LAB
Rank in Stocks
#15242
Standard BioTools Inc., together with its subsidiaries, develops, manufactures,... Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Share Price
$0.6942
Last synced: 2026-11-09
Market Cap
$274.01M
Change (1 day)
9.15%
Change (1 year)
-41.66%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Standard BioTools Inc. (LAB)
Category
Healthcare
Operating Margin for Standard BioTools Inc. (LAB)
Operating Margin as of November 2026 TTM: -94.80%
According to Standard BioTools Inc.'s latest financial reports, its current operating margin (TTM) is -94.80%. At the end of 2025 the company had an operating margin of -109.34%.
Operating Margin history for Standard BioTools Inc. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -94.80% | -13.30% |
| 2025 | -109.34% | 8.84% |
| 2024 | -100.46% | 39.47% |
| 2023 | -72.03% | -39.29% |
| 2022 | -118.64% | 129.66% |
| 2021 | -51.66% | 39.85% |
| 2020 | -36.94% | -16.46% |
| 2019 | -44.22% | 3.71% |
| 2018 | -42.64% | -25.52% |
| 2017 | -57.25% | -18.30% |
| 2016 | -70.07% | 60.27% |
| 2015 | -43.72% | -1.77% |
| 2014 | -44.51% | 76.49% |
| 2013 | -25.22% | -26.96% |
| 2012 | -34.53% | -20.27% |
| 2011 | -43.31% | -0.25% |
| 2010 | -43.42% | -38.83% |
| 2009 | -70.98% | -63.13% |
| 2008 | -192.50% | -40.47% |
| 2007 | -323.38% | -4.49% |
| 2006 | -338.59% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 22.24% | -100.23% |
US
|
|
| -3.59% | -99.96% |
US
|
|
| 0.53% | -100.01% |
US
|
|
| 5.28% | -100.06% |
US
|
|
| 0.00% | -100.00% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Standard BioTools Inc.'s operating margin
What is Standard BioTools Inc.'s operating margin?
Standard BioTools Inc.'s operating margin is -94.80%, as of Nov 2026.
What was Standard BioTools Inc.'s operating margin in 2025?
In 2025, Standard BioTools Inc.'s operating margin was -109.34%, compared with -100.46% in 2024.
How has Standard BioTools Inc.'s operating margin changed since 2020?
From 2020 to 2025, Standard BioTools Inc.'s operating margin was highest in 2020 (-36.94%) and lowest in 2022 (-118.64%).
How does Standard BioTools Inc.'s operating margin compare with similar companies?
Standard BioTools Inc.'s operating margin (-94.80%) is lower than that of all 5 similar companies listed above. The highest among them is Sirona Dental Systems, Inc., with 22.24%.